Evidence map›Paper›PMID 26962088›Full record

ArticleJournal of clinical microbiology2016

Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from Stool.

Collette Fitzgerald, Mary Patrick, Anthony Gonzalez, Joshua Akin, Christopher R Polage, Kate Wymore, Laura Gillim-Ross, Karen Xavier, Jennifer Sadlowski, Jan Monahan and 23 more

Open access · bronzeAbstract readComparative StudyEvaluation StudyMulticenter Study
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
8.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Capturing clinically relevantMicrobial genomics · 2024
    Article
  5. Diagnostic performance of microscopic stool examination inJournal of general and family medicine · 2023
    Article
  6. Article
  7. Genome Sequence Analysis and Characterization of Shiga Toxin 2 Production byFrontiers in cellular and infection microbiology · 2022
    Article
  8. Evidence of False Positivity forOpen forum infectious diseases · 2021
    Article
  9. Article
  10. Article
  11. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  12. Article
  13. Impact of Culture-Independent Diagnostic Testing on Recovery of Enteric Bacterial Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Observational
  14. Article
  15. New Developments in Rapid Diagnostic Testing for Children.Infectious disease clinics of North America · 2018
    Review
  16. Article
  17. Article
  18. Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 1 country.

Collette FitzgeraldCenters for Disease Control and Prevention, Atlanta, Georgia, USA chf3@cdc.gov.
Mary PatrickCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Anthony GonzalezSacramento County Public Health Laboratory, Sacramento, California, USA.
Joshua AkinSacramento County Public Health Laboratory, Sacramento, California, USA.
Christopher R PolageUniversity of California Davis School of Medicine, Sacramento, California, USA.
Kate WymoreCalifornia Emerging Infections Program, Oakland, California, USA.
Laura Gillim-RossColorado Department of Public Health and Environment, Denver, Colorado, USA.
Karen XavierColorado Department of Public Health and Environment, Denver, Colorado, USA.
Jennifer SadlowskiColorado Department of Public Health and Environment, Denver, Colorado, USA.
Jan MonahanExempla St. Joseph Hospital, Denver, Colorado, USA.
Sharon HurdConnecticut Emerging Infections Program, New Haven, Connecticut, USA.
Suzanne DahlbergYale-New Haven Hospital, New Haven, Connecticut, USA.
Robert JerrisChildren's Healthcare of Atlanta, Atlanta, Georgia, USA.
Renee WatsonChildren's Healthcare of Atlanta, Atlanta, Georgia, USA.
Monica SantoveniaCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
David MitchellCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Cassandra HarrisonCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Melissa Tobin-D'AngeloGeorgia Department of Public Health, Atlanta, Georgia, USA.
Mary DeMartinoState Hygienic Laboratory at the University of Iowa, Iowa City, Iowa, USA.
Michael PentellaState Hygienic Laboratory at the University of Iowa, Iowa City, Iowa, USA.
Jafar RazeqMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Celere LeonardMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Carrianne JungMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Ria Achong-BoweMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Yaaqobah EvansMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Damini JainMaryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA.
Billie JuniMinnesota Department of Health, St. Paul, Minnesota, USA.
Fe LeanoMinnesota Department of Health, St. Paul, Minnesota, USA.
Trisha RobinsonMinnesota Department of Health, St. Paul, Minnesota, USA.
Kirk SmithMinnesota Department of Health, St. Paul, Minnesota, USA.
Rachel M GittelmanPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Charles GarriganPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Irving NachamkinPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Maryland Department of Health · USCenters for Disease Control and Prevention · USMinnesota Department of Health · USColorado Department of Public Health and Environment · USUniversity of Pennsylvania · USCalifornia Department of Public Health · USChildren's Healthcare of Atlanta · USUniversity of Iowa · USGeorgia Department of Public Health · USSt. Joseph Medical Center in Tacoma · USUniversity of California, Davis · USYale New Haven Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of culture-independent diagnostic tests (CIDTs), such as stool antigen tests, as standalone tests for the detection of Campylobacter in stool is increasing. We conducted a prospective, multicenter study to evaluate the performance of stool antigen CIDTs compared to culture and PCR for Campylobacter detection. Between July and October 2010, we tested 2,767 stool specimens from patients with gastrointestinal illness with the following methods: four types of Campylobacter selective media, four commercial stool antigen assays, and a commercial PCR assay. Illnesses from which specimens were positive by one or more culture media or at least one CIDT and PCR were designated "cases." A total of 95 specimens (3.4%) met the case definition. The stool antigen CIDTs ranged from 79.6% to 87.6% in sensitivity, 95.9 to 99.5% in specificity, and 41.3 to 84.3% in positive predictive value. Culture alone detected 80/89 (89.9% sensitivity) Campylobacter jejuni/Campylobacter coli-positive cases. Of the 209 noncases that were positive by at least one CIDT, only one (0.48%) was positive by all four stool antigen tests, and 73% were positive by just one stool antigen test. The questionable relevance of unconfirmed positive stool antigen CIDT results was supported by the finding that noncases were less likely than cases to have gastrointestinal symptoms. Thus, while the tests were convenient to use, the sensitivity, specificity, and positive predictive value of Campylobacter stool antigen tests were highly variable. Given the relatively low incidence of Campylobacter disease and the generally poor diagnostic test characteristics, this study calls into question the use of commercially available stool antigen CIDTs as standalone tests for direct detection of Campylobacter in stool.

Indexed as

AdolescentAdultAgedAged, 80 and overBacteriological TechniquesCampylobacterCampylobacter InfectionsChildChild, PreschoolDiagnostic Tests, RoutineFecesFemaleHumansImmunoassayInfantMale

Identifiers

PMID26962088
PMCPMC4844741
OpenAlexW2295215846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.